☆ 4.6 Letter

The miR-17∼92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 185, Issue 3, Pages 616-620

Publisher

WILEY

DOI: 10.1111/bjh.15591

Keywords

miR-17 similar to 92 cluster; mantle cell lymphoma; cell metabolism; mTORC1; STK11; AMPK; TSC pathway

Categories

Hematology

Funding

NCI NIH HHS [R01 CA090400] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemistry & Molecular Biology

TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling

Jianling Xie, Stuart P. De Poi, Sean J. Humphrey, Leanne K. Hein, John B. Bruning, Wenru Pan, Luke A. Selth, Timothy J. Sargeant, Christopher G. Proud

Summary: The study demonstrates that various recurrent Rheb mutations drive hyperactive mTORC1 signaling through different levels of insensitivity to the main inhibitor of Rheb, tuberous sclerosis complex. Among them, two activated mutants, Rheb-T23M and E40K, significantly promote cell growth, proliferation, and anchorage-independent growth, leading to enhanced tumor growth in vivo. Proteomic analysis reveals that these mutants activate distinct oncogenic pathways, with Rheb-T23M enhancing anaerobic glycolysis and Rheb-E40K regulating eEF2 and autophagy, possibly through interactions with AMPK.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Add to Collection

Article Oncology

miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma

Yuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano, Yuichi Tokuda, Hiroaki Nagata, Kentaro Mizuhara, Yoko Katsuragawa-Taminishi, Reiko Isa, Takahiro Fujino, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Kei Tashiro, Junya Kuroda

Summary: The miR-17-92 cluster activates the BCR signaling pathway in MCL by regulating BTG2, resulting in cell proliferation. Silencing BTG2 leads to overactivation of the BCR signaling pathway and cell proliferation. These findings contribute to predicting therapeutic efficacy and improving outcomes in MCL.

CANCER SCIENCE (2023)

Add to Collection

Article Medicine, Research & Experimental

miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster

Yan Sweat, Ryan J. Ries, Mason Sweat, Dan Su, Fan Shao, Steven Eliason, Brad A. Amendt

Summary: Anaplastic thyroid cancer is a highly metastatic cancer expressing high levels of the miR-17-92 cluster. Inhibition of miR-17 unexpectedly promotes the expression of other oncogenic miRs within the cluster, leading to cancer progression. The study suggests a complex regulatory role of miR-17 in thyroid tumor growth.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection

Article Cell Biology

miR-17∼ 92 exerts stage-specific effects in adult V-SVZ neural stem cell lineages

Fabrizio Favaloro, Annina M. DeLeo, Ana C. Delgado, Fiona Doetsch

Summary: Neural stem cells in the adult ventricular-subventricular zone play a crucial role in generating neurons and glia. MicroRNAs, specifically miR-17 and miR-92, are found to be highly upregulated in the activated stem cells and transit amplifying cells. Their deletion has stage-specific effects, affecting proliferation and differentiation of various subpopulations within the adult ventricular-subventricular zone. These findings highlight the importance of miR-17 and miR-92 in regulating neural stem cell function.

CELL REPORTS (2022)

Add to Collection

Article Cell Biology

The miR-17∼92 miRNAs promote plasma cell differentiation by suppressing SOCS3-mediated NIK degradation

Jun Xie, Ying Du, Dewang Liu, Jianfeng Wu, Kang Yang, Xiaoyu He, Jiayi Zhao, Peicheng Hong, Kunyu Liao, Huanrong Zhang, Yazhen Hong, John R. Teijaro, Seung Goo Kang, Changchun Xiao, Wen-Hsien Liu

Summary: The miR-17 similar to 92 family microRNAs play a key role in T cell and plasma cell differentiation. In this study, researchers found that the miR-17 similar to 92 family also has important functions in B cell differentiation and function, regulating the key target gene Socs3 in plasma cell differentiation.

CELL REPORTS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

SRSF3 shapes the structure of miR-17-92 cluster RNA and promotes selective processing of miR-17 and miR-20a

Madara Ratnadiwakara, Mohamed N. M. Bahrudeen, Erika Aikio, Piia Takabe, Rebekah M. Engel, Zileena Zahir, Thierry Jarde, Paul J. McMurrick, Helen E. Abud, Minna-Liisa Anko

Summary: This study reveals that Serine-arginine rich splicing factor 3 (SRSF3) plays a crucial role in the processing of miR-17-92 cluster miRNAs in pluripotent and cancer cells. SRSF3 binding to CNNC motifs downstream of Drosha cleavage sites is required for efficient processing of the cluster. The interaction between SRSF3 and miR-17-92 results in changes in RNA structure and an increase in miR-17 and miR-20a levels, promoting self-renewal and contributing to colorectal cancer pathogenesis.

EMBO REPORTS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Epstein-Barr Virus miR-BART1-3p Regulates the miR-17-92 Cluster by Targeting E2F3

Myung Chan Park, Hyoji Kim, Hoyun Choi, Mee Soo Chang, Suk Kyeong Lee

Summary: The EBV-associated miRNA miR-BART1-3p plays a role in cell cycle regulation and cell growth by targeting E2F3. Moreover, miR-BART1-3p may also affect the expression of the miR-17-92 cluster by downregulating E2F3.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Prognostic Value of the miR-17∼92 Cluster in Chronic Lymphocytic Leukemia

Sylwia Chocholska, Michal Zarobkiewicz, Agata Szymanska, Natalia Lehman, Justyna Wos, Agnieszka Bojarska-Junak

Summary: The aim of this study was to investigate the expression of miR-17 similar to 92 cluster members in CLL patients. The study provides new evidence regarding the heterogeneity of miR-17 similar to 92 cluster members' expression in CLL patients. High miR-20a expression can be considered an independent favorable prognostic factor.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Genetics & Heredity

miR-17-92 cluster in osteoarthritis: Regulatory roles and clinical utility

Xuefeng Pan, Xiao Cen, Xiner Xiong, Zhihe Zhao, Xinqi Huang

Summary: Osteoarthritis is a common joint disease, especially in the elderly population. It leads to joint pain and disability, reducing patients' quality of life and increasing social burden. The pathophysiology of osteoarthritis is characterized by cartilage hypertrophy or defect, subchondral bone sclerosis, and synovitis. Research suggests that certain miRNAs are closely related to the pathological processes of osteoarthritis, providing new avenues for diagnosis and treatment.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Cell Biology

HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster

Kexin Li, Jiongyu Chen, Xiaoying Lou, Yiling Li, Benheng Qian, Danfei Xu, Yue Wu, Shaohui Ma, Donghong Zhang, Wei Cui

Summary: The study revealed that the dynamic changes in 25 m6A regulators were associated with the clinical features and prognosis of patients with esophageal cancer, with HNRNPA2B1 possibly affecting the prognosis of esophageal cancer patients by regulating the miR-17-92 cluster.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer

Bei Liu, Jiaxi Zhang, Xue Meng, Shelly M. Xie, Fang Liu, Heli Chen, Demin Yao, Minglei Li, Minghui Guo, Haitao Shen, Xianghong Zhang, Lingxiao Xing

Summary: This study reveals that ETV4 activates mTORC1 in non-small cell lung cancer cells by controlling HK1 expression and glycolysis-lactate production. Furthermore, G3BP2 and HDAC6 play important roles in inhibiting mTORC1 through regulating TSC2. Therefore, the HDAC6-G3BP2 complex might represent a critical adaptive mechanism for cell survival under low-lactate challenges.

ONCOGENE (2023)

Add to Collection

Article Urology & Nephrology

Endothelial-Derived miR-17∼92 Promotes Angiogenesis to Protect against Renal Ischemia-Reperfusion Injury

Takuto Chiba, Debora M. Cerqueira, Yao Li, Andrew J. Bodnar, Elina Mukherjee, Katherine Pfister, Yu Leng Phua, Kai Shaikh, Brandon T. Sanders, Shelby L. Hemker, Patrick J. Pagano, Yijen L. Wu, Jacqueline Ho, Sunder Sims-Lucas

Summary: miR-17 similar to miR-92 is dynamically regulated in renal endothelial cells after renal IRI and plays a role in the pathogenesis of AKI. Endothelial-specific miR-17 similar to miR-92 knockout exacerbates renal IRI, promoting renal tubular injury, reducing renal blood flow, and increasing oxidative stress in the kidneys. miR-17 similar to miR-92 is critical in the angiogenic response after renal IRI, and treatment with miR-18a and miR-19b mimics can mitigate the damage.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

TMAO Upregulates Members of the miR-17/92 Cluster and Impacts Targets Associated with Atherosclerosis

Laura Diez-Ricote, Paloma Ruiz-Valderrey, Victor Mico, Ruth Blanco, Joao Tome-Carneiro, Alberto Davalos, Jose M. Ordovas, Lidia Daimiel

Summary: Atherosclerosis is strongly influenced by lifestyle and can be regulated by the miR-17/92 cluster. TMAO, a metabolite of choline, betaine, and L-carnitine, has been associated with atherosclerosis. This study found that TMAO modulates the expression of the miR-17/92 cluster and increases the expression of target genes related to inflammation and blood clotting, potentially promoting atherosclerosis and cardiovascular disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Mathematics, Interdisciplinary Applications

Stochastic P-Bifurcation in a Delayed Myc/E2F/miR-17-92 Network

Zikun Han, Qiubao Wang, Hao Wu, Zhouyu Hu

Summary: This study focuses on the behavior of the Myc/E2F/miR-17-92 network under Gaussian white noise. The system exhibits bifurcation and a coexistence pattern of high and low protein concentrations. The research methods include stochastic center manifold theory, normal form theory, and stochastic averaging method.

INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS (2022)

Add to Collection

Article Oncology

Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis

Jingyao Wang, Xiqi Peng, Rongkang Li, Kaihao Liu, Chunduo Zhang, Xuan Chen, Guocheng Huang, Liwen Zhao, Zebo Chen, Yongqing Lai

Summary: This study confirmed the overexpression of serum miR-17-92 cluster in bladder cancer, and the three cluster members can serve as promising diagnostic biomarkers.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK- anaplastic large cell lymphoma by regulating the DNA helicase HELLS

Valentina Fragliasso, Akanksha Verma, Gloria Manzotti, Annalisa Tameni, Rohan Bareja, Tayla B. Heavican, Javeed Iqbal, Rui Wang, Danilo Fiore, Valentina Mularoni, Wing C. Chan, Priscillia Lhoumaud, Jane Skok, Eleonora Zanetti, Francesco Merli, Alessia Ciarrocchi, Oliver Elemento, Giorgio Inghirami

LEUKEMIA (2020)

Add to Collection

Article Hematology

Cereblon harnesses Myc-dependent bioenergetics and activity of CD8(+) T lymphocytes

Rebecca S. Hesterberg, Matthew S. Beatty, Ying Han, Mario R. Fernandez, Afua A. Akuffo, William E. Goodheart, Chunying Yang, Shiun Chang, Christelle M. Colin, Aileen Y. Alontaga, Jessica M. McDaniel, Adam W. Mailloux, Julia M. R. Billington, Lanzhu Yue, Shonagh Russell, Robert J. Gillies, Sang Y. Yun, Muhammad Ayaz, Nicholas J. Lawrence, Harshani R. Lawrence, Xue-Zhong Yu, Jianing Fu, Lancia N. Darville, John M. Koomen, Xiubao Ren, Jane Messina, Kun Jiang, Timothy J. Garrett, Anjali M. Rajadhyaksha, John L. Cleveland, Pearlie K. Epling-Burnette

BLOOD (2020)

Add to Collection

Article Hematology

Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1

Gehong Dong, Yuping Li, Logan Lee, Xuxiang Liu, Yunfei Shi, Xiaoqian Liu, Alyssa Bouska, Qiang Gong, Lingbo Kong, Jinhui Wang, Chih-Hong Lou, Timothy W. McKeithan, Javeed Iqbal, Wing C. Chan

Summary: The study utilized two different CRISPR/Cas9 approaches to generate PRDM1-/- primary NK cells to investigate the role of PRDM1 in NK cell homeostasis. Results showed that PRDM1(-/-) NK cells exhibited higher proliferation rate and lower apoptosis compared to wild-type cells, with gene expression profiling revealing enrichment in pathways associated with proliferation and cell cycle.

HAEMATOLOGICA (2021)

Add to Collection

Article Medicine, Research & Experimental

Metabolic reprogramming augments potency of human pSTAT3-inhibited iTregs to suppress alloreactivity

Kelly Walton, Mario R. Fernandez, Elizabeth M. Sagatys, Jordan Reff, Jongphil Kim, Marie Catherine Lee, John Kiluk, Jane Yuet Ching Hui, David McKenna, Meghan Hupp, Colleen Forster, Michael A. Linden, Nicholas J. Lawrence, Harshani R. Lawrence, Joseph Pidala, Steven Z. Pavletic, Bruce R. Blazar, Said M. Sebti, John L. Cleveland, Claudio Anasetti, Brian C. Bett

JCI INSIGHT (2020)

Add to Collection

Letter Hematology

A novel MYC-non-IG fusion in refractory diffuse large B-cell lymphoma

Cheng Wang, Pamela A. Althof, Chengfeng Bi, Weiwei Zhang, Alyssa C. Bouska, Tian Tian, Xuan Zhang, Nanxi Jiang, Guohua Yu, Hongxia Cheng, Javeed Iqbal, Julie M. Vose, Jennifer N. Sanmann, Kai Fu

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Oncology

Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma

Waseem Lone, Alyssa Bouska, Sunandini Sharma, Catalina Amador, Mallick Saumyaranjan, Tyler A. Herek, Tayla B. Heavican, Jiayu Yu, Soon Thye Lim, Choon Kiat Ong, Graham W. Slack, Kerry J. Savage, Andreas Rosenwald, German Ott, James R. Cook, Andrew L. Feldman, Lisa M. Rimsza, Timothy W. McKeithan, Timothy C. Greiner, Dennis D. Weisenburger, Federica Melle, Giovanna Motta, Stefano Pileri, Julie M. Vose, Wing C. Chan, Javeed Iqbal

Summary: This study revealed differences in miRNA expression and signaling pathways among different subtypes of T-cell lymphoma, identifying certain miRNAs and possible regulatory mechanisms associated with disease occurrence and progression.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

Mario R. Fernandez, Franz X. Schaub, Chunying Yang, Weimin Li, Seongseok Yun, Stephanie K. Schaub, Frank C. Dorsey, Min Liu, Meredith A. Steeves, Andrea Ballabio, Alexandar Tzankov, Zhihua Chen, John M. Koomen, Anders E. Berglund, John L. Cleveland

CANCER RESEARCH (2022)

Add to Collection

Article Hematology

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Tyler A. Herek, Alyssa Bouska, Waseem Lone, Sunandini Sharma, Catalina Amador, Tayla B. Heavican, Yuping Li, Qi Wei, Dylan Jochum, Timothy C. Greiner, Lynette Smith, Stefano Pileri, Andrew L. Feldman, Andreas Rosenwald, German Ott, Soon Thye Lim, Choon Kiat Ong, Joo Song, Elaine S. Jaffe, Gang Greg Wang, Louis Staudt, Lisa M. Rimsza, Julie Vose, Francesco d'Amore, Dennis D. Weisenburger, Wing C. Chan, Javeed Iqbal

Summary: This study investigated the role of DNMT3A mutations in PTCL and found that DNMT3A mutations, particularly in PTCL-TBX21 cases, are associated with inferior overall survival and enrichment of activated CD8+ T-cell cytotoxic gene signatures. Genomewide methylation analysis demonstrated hypomethylation of target genes regulating interferon-gamma, T-cell receptor signaling, and EOMES in DNMT3A-mutant PTCL-TBX21 cases. Functional experiments using mouse models and in vitro cell cultures confirmed the impact of DNMT3A mutations on T-cell activation and cytotoxic effector cell transcriptional regulation.

BLOOD (2022)

Add to Collection

Article Oncology

Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice

Catalina Amador, Alyssa Bouska, George Wright, Dennis D. Weisenburger, Andrew L. Feldman, Timothy C. Greiner, Waseem Lone, Tayla Heavican, Lynette Smith, Stefano Pileri, Valentina Tabanelli, German Ott, Andreas Rosenwald, Kerry J. Savage, Graham Slack, Won Seog Kim, Young Hyeh, Yuping Li, Gehong Dong, Joo Song, Sarah Ondrejka, James R. Cook, Carlos Barrionuevo, Soon Thye Lim, Choon Kiat Ong, Jennifer Chapman, Giorgio Inghirami, Philipp W. Raess, Sharathkumar Bhagavathi, Clare Gould, Piers Blombery, Elaine Jaffe, Stephan W. Morris, Lisa M. Rimsza, Julie M. Vose, Louis Staudt, Wing C. Chan, Javeed Iqbal

Summary: This study aims to classify PTCL subtypes using transcriptomic signatures to improve diagnostic accuracy and precision in clinical practice.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma

Gehong Dong, Xuxiang Liu, Lifu Wang, Wenjuan Yin, Alyssa Bouska, Qiang Gong, Kunal Shetty, Lu Chen, Sunandini Sharma, Jibin Zhang, Carmen Lome-Maldonado, Leticia Quintanilla-Martinez, Yuping Li, Joo Y. Song, Wenyan Zhang, Yunfei Shi, Jinhui Wang, Lingbo Kong, Xiwei Wu, Jingwen Wang, Hong-Gang Liu, Lingfei Kong, Wenyong Sun, Weiping Liu, Lili Wang, Timothy W. McKeithan, Javeed Iqbal, Wing C. Chan

Summary: This study provides a comprehensive genomic analysis and clinical study of extra-nodal NK/T-cell lymphoma, nasal type (ENKTCL). It identifies factors associated with overall survival, reveals frequent oncogenic activation of the JAK/STAT3 pathway, and identifies genetic clusters associated with different clinical outcomes. The study also highlights a novel functional cooperation between activating STAT3 mutations and loss of the TSG, PRDM1.

LEUKEMIA (2022)

Add to Collection

Article Oncology

SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters

Elisabeth Gross, Ralf-Axel Hilger, Franziska Lea Schuemann, Marcus Bauer, Alyssa Bouska, Christian Rohde, Edith Willscher, Jana Luetzkendorf, Lutz Peter Mueller, Bayram Edemir, Thomas Mueller, Marco Herling, Mascha Binder, Claudia Wickenhauser, Javeed Iqbal, Guido Posern, Thomas Weber

Summary: Histone lysine methyltransferase EZH2 is frequently altered in lymphoid tumors, and its overexpression or mutation is associated with tumor progression and resistance to chemotherapy. In this study, the combination treatment with SAM-competitive EZH2 inhibitors led to platinum resistance due to increased platinum efflux. Off-target effects of the inhibitors resulted in the upregulation of proteins associated with chemotherapy resistance.

CANCERS (2023)

Add to Collection

Article Oncology

The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL

Moritz Otte, Johanna Stachelscheid, Markus Glass, Linus Wahnschaffe, Qu Jiang, Waseem Lone, Aleksandr Ianevski, Tero Aittokallio, Javeed Iqbal, Michael Hallek, Stefan Huettelmaier, Alexandra Schrader, Till Braun, Marco Herling

Summary: T-prolymphocytic leukemia (T-PLL) is a rare and poor-prognostic mature T-cell leukemia. Elevated expression of miR-141/200c cluster in T-PLL cells promotes cell proliferation and alters the expression of genes involved in cell survival and differentiation. Low expression of STAT4, a target gene of miR-141/200c, is associated with an immature phenotype of T-PLL cells and shortened overall survival of T-PLL patients. This study reveals the oncogenic role of miR-141/200c-STAT4 signaling pathway in T-PLL, shedding light on the involvement of non-protein-coding genes in the pathogenesis of this devastating disease.

CANCERS (2023)

Add to Collection

Article Medicine, Research & Experimental

Modulating the polyamine/hypusine axis controls generation of CD8+tissue-resident memory T cells

Aya G. Elmarsafawi, Rebecca S. Hesterberg, Mario R. Fernandez, Chunying Yang, Lancia N. F. Darville, Min Liu, John M. Koomen, Otto Phanstiel, Reginald Atkins, John E. Mullinax, Shari A. Pilon-Thomas, Frederick L. Locke, Pearlie K. Epling-Burnette, John L. Cleveland

Summary: Glutaminolysis is a characteristic of T cell activation and metabolic reprogramming, and the polyamine-hypusine axis can be modulated to regulate the development of tissue-resident memory T cells and enhance therapeutic outcomes.

JCI INSIGHT (2023)

Add to Collection

Article Medicine, Research & Experimental

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

Sylvain Carras, Dimitri Chartoire, Sylvain Mareschal, Mael Heiblig, Antoine Marcais, Remy Robinot, Mirjam Urb, Roxane M. Pommier, Edith Julia, Amel Chebel, Aurelie Verney, Charlotte Bertheau, Emilie Bardel, Caroline Fezelot, Lucien Courtois, Camille Lours, Alyssa Bouska, Sunandini Sharma, Christine Lefebvre, Jean-Pierre Rouault, David Sibon, Anthony Ferrari, Javeed Iqbal, Laurence de Leval, Philippe Gaulard, Alexandra Traverse-Glehen, Pierre Sujobert, Mathieu Blery, Gilles Salles, Thierry Walzer, Emmanuel Bachy, Laurent Genestier

Summary: Chronic TCR stimulation may drive T cell lymphomagenesis, but does not affect PTCL cell survival. NK cell-like reprogramming may occur in PTCL cells, with expression of NK receptors and downstream signaling molecules.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Oncology

TFEB Links MYC Signaling to Epigenetic Control of Myeloid Differentiation and Acute Myeloid Leukemia

Seongseok Yun, Nicole D. Vincelette, Xiaoqing Yu, Gregory W. Watson, Mario R. Fernandez, Chunying Yang, Taro Hitosugi, Chia-Ho Cheng, Audrey R. Freischel, Ling Zhang, Weimin Li, Hsinan Hou, Franz X. Schaub, Alexis R. Vedder, Ling Cen, Kathy L. McGraw, Jungwon Moon, Daniel J. Murphy, Andrea Ballabio, Scott H. Kaufmann, Anders E. Berglund, John L. Cleveland

Summary: MYC oncoproteins regulate cell proliferation, metabolism, and tumorigenesis in AML by suppressing TFEB; TFEB acts as a tumor suppressor and induces differentiation through IDH1/IDH2 in AML; the TFEB-IDH1/IDH2-TET2 axis is a targetable vulnerability in AML.

BLOOD CANCER DISCOVERY (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.